Indoco Remedies Ltd share price logo

Indoco Remedies Ltd

NSE: INDOCO

BSE: 532612

Small Cap

Pharma Sector

₹208.30

-1.20

(-0.57%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Indoco Remedies shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-49%

Searches for Indoco Remedies on INDmoney have decreased by 49% over the last 30 days.

Key Events for Indoco Remedies

Last Dividend Declared

₹0.20 per share, declared on 07/05/2026

View Dividend History

Indoco Remedies Stock Performance

as on October 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹205.10
    ₹210.00
    downward going graph

    1.54%

    Downside

    0.82%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹162.19
    ₹288.00
    downward going graph

    22.14%

    Downside

    38.26%

    Upside

    downward going graph

Indoco Remedies share price movements today

Previous Close
₹209.50
Open
₹208.65
Volume
64.73K
Upper Circuit
₹251.40
Lower Circuit
₹167.60
Day's Low - High
₹205.10 - ₹210.00
52 Week Low - High
₹162.19 - ₹288.00

Indoco Remedies Historical Returns

1 Month Return
-16.78 %
3 Month Return
-4.55 %
1 Year Return
-24.95 %
3 Year Return
-34.08 %
5 Year Return
-56.17 %

Indoco Remedies Fundamentals

as on October 30, 2026 at 4:01 pm IST

Market Cap

₹1,922.99 Cr

Return on Equity (ROE)

-0.28

PE Ratio (TTM)

61.08

Return on capital employed (ROCE)

4.23

Industry PE ratio

51.39

Beta (LTM)

0.9

P/B Ratio

1.38

Dividend Yield

0

PEG Ratio

3.83

Quarterly Earnings Growth YOY

-311.4

EPS (TTM)

-10.69

Book Value

101.76

Indoco Remedies Stock Valuation

as on October 30, 2026 at 4:01 pm IST

Indoco Remedies in the last 5 years

  • Overview

  • Trends

Lowest (-705.32x)

April 24, 2019

Industry (51.39x)

October 29, 2026

Today (61.08x)

October 29, 2026

Highest (855.53x)

September 2, 2026

LowHigh

Today’s Price to Earnings Ratio: 61.08x

Indoco Remedies Technical Analysis

Track how Indoco Remedies technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish1
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.23
Bearish
CCI (20)
-104.13
Bullish
RSI (14)
36.56
Neutral
Momentum (10)
-2.2
Bearish
ADI (14)
27.55
Bearish
Ultimate Oscillator (7,14,28)
35.29
Neutral

Moving Averages

Name

Value

Action

SMA (20)
208.59
Bearish
EMA (20)
208.12
Bearish
VWMA (20)
208.18
Bearish
SMA (50)
208.11
Bearish
EMA (50)
207.92
Bearish
SMA (200)
207.1
Bearish
EMA (200)
207.28
Bearish
KAMA (200)
208.38
Bearish
DEMA (200)
207.19
Bearish

Indoco Remedies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indoco Remedies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Indoco Remedies Ltd image
Indoco Remedies Ltd
HOLD1,922.99-11.23%0.77-991,845
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,998.80-0.63%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY14,716.1311.01%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA5,726.51-6.31%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY12,377.9333.17%0.682811,703
See all

Market expectation of Indoco Remedies Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

0.00%

Buy

75.00%

Hold

25.00%

Sell

Indoco Remedies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
458.75
439.08
424.29
430.66
402.45
383.89
430.86
471.83
434.34
455.9
466.22
506.92
Other Income
2.35
22.39
1.03
1.56
1.84
2.02
1.63
0.76
0.98
3.7
99.52
39.11
Total Income
461.77
472.03
432.52
434.22
412.39
392.23
441.3
485.43
446.34
479.31
567.02
559.28
Expenses
404.72
400.77
383.72
392.41
398.52
390.99
422.14
442.15
420
425.9
426.48
473.74
Operating Profit
54.03
38.31
40.57
38.25
3.93
-7.1
8.72
29.68
14.34
30
39.74
33.18
Operating Profit Margin %
11.78%
8.73%
9.56%
8.88%
0.98%
-1.85%
2.02%
6.29%
3.3%
6.58%
8.52%
6.55%
Profit Before Interest, Tax and Depreciation
57.05
71.26
48.8
41.81
13.87
1.24
19.16
43.28
26.34
53.41
140.54
85.54
Interest
10.07
12.05
14.31
17.83
16.11
17.98
26.12
24.56
25.64
45.92
28.29
26.91
Depreciation
24.35
26.23
27.52
28.82
28.72
28.78
29.7
32.25
32.01
32.49
34.53
34.44
Profit Before Tax
22.63
32.98
6.97
-4.84
-30.96
-45.52
-36.66
-13.53
-31.31
-25
77.72
24.19
Tax Paid
7.07
10.95
5.15
5.17
-2.56
-4.18
-0.31
-4.32
-1.86
-1.32
12.28
4.72
Profit After Tax
15.56
22.03
1.82
-10.01
-28.4
-41.34
-36.35
-9.21
-29.45
-23.68
65.44
19.47
Total Net profit including share of profit / Loss from associate company
15.56
22.03
1.82
-10.01
-28.4
-41.34
-36.35
-9.21
-29.45
-23.68
65.44
19.47
EPS
1.69
2.39
0.2
-1.09
-3.08
-4.48
-3.94
-1
-3.2
-2.57
7.09
2.11
Actual EPS
1.69
2.39
0.2
-1.09
-3.08
-4.48
-3.94
-1
-3.2
-2.57
7.09
2.11
Adjusted EPS
1.69
2.39
0.2
-1.09
-3.08
-4.48
-3.94
-1
-3.2
-2.57
7.09
2.11
Diluted EPS
1.69
2.39
0.2
-1.08
-3.08
-4.48
-3.94
-1
-3.19
-2.56
7.09
2.11

Indoco Remedies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
1,021.03
942.08
1,079.98
1,218.61
1,503.73
1,640.05
1,788.22
1,641.29
1,792.94
Other Income
4.69
6.14
2.44
3.12
2.33
2.34
21.38
6.44
3.33
Total Income
1,049.99
974.59
1,109.03
1,244.65
1,543.08
1,670.95
1,838.67
1,671.36
1,848.65
Expenses
910.37
891.79
983.38
1,017.26
1,213.41
1,382.51
1,572.98
1,565.66
1,706.46
Operating Profit
110.66
50.29
96.6
201.35
290.32
257.54
215.24
75.63
86.48
Operating Profit Margin %
10.84%
5.34%
8.94%
16.52%
19.31%
15.7%
12.04%
4.61%
4.82%
Profit Before Interest, Tax and Depreciation
139.62
82.8
125.65
227.39
329.67
288.44
265.69
105.7
142.19
Interest
23.51
20.54
26.25
22.26
14.14
25.03
38.02
66.23
122.25
Depreciation
67.71
71.57
70.82
73.13
78.96
70.61
91.87
113.84
126.45
Profit Before Tax
48.4
-9.31
28.58
132
236.57
192.8
135.8
-74.37
-106.51
Tax Paid
7.24
-6.41
4.46
38.95
81.77
50.55
38.79
3.58
-7.81
Profit After Tax
41.16
-2.9
24.12
93.05
154.8
142.25
97.01
-77.95
-98.7
Total Net profit including share of profit / Loss from associate company
41.16
-2.9
24.12
93.05
154.8
142.25
97.01
-77.95
-98.7
EPS
4.47
-0.32
2.62
10.1
16.8
15.44
10.53
-8.46
-10.7
Actual EPS
4.47
-0.32
2.62
10.1
16.8
15.44
10.53
-8.46
-10.7
Adjusted EPS
4.47
-0.32
2.62
10.1
16.8
15.44
10.53
-8.46
-10.7
Diluted EPS
4.47
-0.32
2.62
10.1
16.8
15.44
10.51
-8.45
-10.69

Indoco Remedies Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
112.23
88.64
122.72
132.11
122.85
82.22
173.83
178.83
156.7
94.94
192.23
Cash Flow from Investing Activities
-13.01
19.02
4.02
-6.81
2.53
10.16
3.91
-0.93
-5.91
-339.11
-101.61
Cash Flow from Financing Activities
-1.61
131.58
-38.77
-16.15
-63.95
-29.87
-44.36
22.81
280.42
241.43
-76.8
Net Cash Flow
-0.11
49.66
-51.48
12.22
2.97
-14.34
8.05
-6.54
3.93
-2.75
13.82

Indoco Remedies Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
58.74%
58.72%
58.75%
58.75%
58.8%
58.9%
58.9%
58.9%
58.9%
58.86%
58.86%
58.92%
DII
19.56%
19.41%
18.67%
18.24%
18.9%
18.75%
18.96%
18.16%
18.15%
18.15%
17.68%
16.64%
FII
1.69%
1.91%
1.47%
1.7%
1.25%
1.24%
1.22%
1.25%
1.1%
0.94%
1.27%
1.64%
Public
20%
19.92%
21.07%
21.28%
21.03%
21.02%
20.83%
21.6%
21.77%
21.9%
22.04%
22.66%
Total Outstanding Shares
9,21,50,355
9,21,82,205
9,21,82,205
9,21,82,205
9,21,82,205
9,22,47,905
9,22,47,905
9,22,47,905
9,22,47,905
9,23,03,605
9,23,03,605
9,23,03,605
Total Shareholders
32,600
33,201
34,511
34,416
34,676
34,497
33,129
33,319
32,659
32,276
32,457
34,098

Mutual Funds Buying / Exiting Indoco Remedies

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Indoco Remedies

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Indoco Remedies

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Nippon India Pharma Fund - Direct Plan - Growth Plan

Nippon India Pharma Fund - Direct Plan - Growth Plan

₹34.99 Cr

₹3.77 Cr (-9.72%)

0.48%

Indoco Remedies Corporate Actions

View detailed summary of the earnings and dividend history of Indoco Remedies.

  • Indoco Remedies Ltd Earnings Results

    Indoco Remedies Ltd’s net profit jumped 331.78% since last year same period to ₹18.38Cr in the Q2 2026-2027. On a quarterly growth basis, Indoco Remedies Ltd has generated -71.72% fall in its net profits since last 3-months.

    Read More

  • Indoco Remedies Ltd Dividends May,2026

    In the quarter ending March 2026, Indoco Remedies Ltd has declared dividend of ₹0.20 per share on 07 May 2026 - translating a dividend yield of 0.10%.

    Read More about Dividends

Indices Featuring Indoco Remedies Stock

Check stock indices that include Indoco Remedies.

BSE Healthcare

₹50,168.37

+474.08 (▲0.95%)

Insights on Indoco Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.27% to 1.64% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 58.86% to 58.92% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 22.04% to 22.66% in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 520.3% return, outperforming this stock by 554.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 135.3% return, outperforming this stock by 160.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 64.99 Cr → 18.38 Cr (in ₹), with an average decrease of 71.7% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 17.16% to 16.44% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INDOCO stock has moved down by -4.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 567.02 Cr → 559.28 Cr (in ₹), with an average decrease of 1.4% per quarter

About Indoco Remedies Ltd

Indoco Remedies Limited is a Mumbaibased pharmaceutical company established in 1947 and currently has a presence in 55 countries with a USD 166 million turnover. It mainly focuses on Formulations Finished Dosage Forms and Active Pharmaceutical Ingredients. It is presently active in therapeutic segments, including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and antifungal. It has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, and is supported by a state-of-the-art RD Centre. AC Nielsen ORGMARG market survey ranks Indoco first in stomatology, ninth in opthalmic and 12th in pediatric segments in terms of prescription generation. It has a marketing network of 1248 medical representatives. To further its goals, the company purchased remaining shares of Xtend Industrial Designers and Engineers in 2014, and acquired a Clinical Research Division from Piramal Enterprise in 2015. It likewise incorporated Indoco Remedies Singapore Pte Limited in 2015 and established a 100% subsidiary in Czech Republic in 2019. It has also launched 8 new products, 5 in Cardiac, 2 in Anti-diabetic and 1 in Dermatology. The company is further patent-recognised for products like Olopatadine, Gliclazide, Brinzolamide, Febuxostat, Rufinamide, Lacosamide, Tapentadol, Aminoindane compound and Pyrazole derivatives. It currently has 3 subsidiary companies under its fold, Xtend Industrial Designers and Engineers Pvt. Ltd., Indoco Remedies Czech sro and Indoco Remedies UK Limited.

Revenue: ₹506.92Cr as on September 2026 (Q2 FY27)
Net Profit: ₹19.47Cr as on September 2026 (Q2 FY27)
Listing date: 14 Jan, 2005
Chairperson Name: Suresh G Kare
OrganisationIndoco Remedies Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOSuresh G Kare
E-voting on sharesClick here to vote

FAQs

What is Indoco Remedies share price today?

Indoco Remedies share price today stands at ₹208.3 as on at the close of the market. Indoco Remedies share today touched a day high of ₹210 and a low of ₹205.1.

What is the 52 week high and 52 week low range for Indoco Remedies share?

Indoco Remedies touched a 52 week high of ₹288 and a 52 week low of ₹162.19. Indoco Remedies share price today i.e. is closed at ₹208.3, which is -27.67% down from its 52 week high and 28.43% up from its 52 week low.

What is Indoco Remedies's market capitalisation today?

Indoco Remedies market capitalisation is ₹1,922.99 Cr as on .

How to buy Indoco Remedies shares?

To buy Indoco Remedies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for INDOCO or Indoco Remedies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Indoco Remedies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Indoco Remedies trading volume today?

Indoco Remedies trading volume is 64.73K as on . This means that 64.73K shares of Indoco Remedies were bought and sold on the stock market during today's trading session.